Erratum to «Kennedy’s disease and partial androgen insensitivity syndrome: Report of 4 cases» [Endocrinol Nutr. 2015;62(5):224-230]

The article “Kennedy's disease and partial androgen insensitivity syndrome: report of 4 cases” was publishe- d in volume 67, issue 5 of the journal ENDOCRINOLOGÍA Y NUTRICIÓN. A table (Table 1) summarising the clinical and hormonal characteristics, as well as the genetic study of the four patients, was provided on page 226.

Table 1.

Clinical and hormonal characteristics and genetic study of the four patients.

Case	1	2	3	4
Current age (years)	41	58	66	70
Age at neurological diagnosis (years)	37	48	50	62
Offspring	No	No	Yes	Yes
Gynaecomastia	Yes	No	Yes	Yes
FSH (IU/l) (1.9−11.3)	4.2	38.9	4.3	3.6
LH (IU/l) (1.5−6.8)	3.3	34.3	5.1	7
Oestradiol (pmol/l) (70−120)	100	184	200	130
Testosterone (nmol/l) (7.6−23)	10.2	36.1	31.1	15.6
Testosterone/SHBG (%) (31.7−61.8)	61.1	39.1	39.5	25.4
SHBG (nmol/l) (9.3−75.2)	16.7	92.3	78.7	62.2
LH after GnRH (IU/l) (4.6−14.5)		36.70	16.20	27.10
FSH after GnRH (IU/l) (2−5.2)		34.6	6.77	4.91
Creatine kinase (μkat/l) (0−4.5)	37.28	3.13	1.38	3.26
CAG triplet number of repeats^a	60	50	60	63
Androgen sensitivity index (20.3−364 IU × nmol/l^2)	33.66	1,238.23	158.61	109.2

The normal range is shown in brackets.

SHBG: sex hormone-binding globulin; CAG triplets: cytosine-adenine-guanine.

a

Pathological range of genetic study: 36–88 CAG.

We have identified an error in the table, whereby some of the values were displaced from their row, leading to confusion and misinterpretation. The table with the values correctly shown is provided in this document.

We would also like to take this opportunity to clarify that in case 1, the dynamic FSH and LH stimulation test could not be performed after administration of 84.6 mmol (100 mg) of intravenous gonadorelin (GnRH).

This correction is intended to rectify the error that may have led to confusion in interpreting the results.